Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Vaccine for Non-infectious Meningitis Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Vaccine for Non-infectious Meningitis Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Polysaccharide Vaccines
      • 1.3.3 Conjugate Vaccines
      • 1.3.4 Combination Vaccines
      • 1.3.5 Men B Vaccines
    • 1.4 Market Segment by Application
      • 1.4.1 Global Vaccine for Non-infectious Meningitis Market Share by Application (2019-2025)
      • 1.4.2 Meningitis
      • 1.4.3 Septicemia
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Vaccine for Non-infectious Meningitis Market Size
      • 2.1.1 Global Vaccine for Non-infectious Meningitis Revenue 2014-2025
      • 2.1.2 Global Vaccine for Non-infectious Meningitis Sales 2014-2025
    • 2.2 Vaccine for Non-infectious Meningitis Growth Rate by Regions
      • 2.2.1 Global Vaccine for Non-infectious Meningitis Sales by Regions 2014-2019
      • 2.2.2 Global Vaccine for Non-infectious Meningitis Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Vaccine for Non-infectious Meningitis Sales by Manufacturers
      • 3.1.1 Vaccine for Non-infectious Meningitis Sales by Manufacturers 2014-2019
      • 3.1.2 Vaccine for Non-infectious Meningitis Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Vaccine for Non-infectious Meningitis Revenue by Manufacturers (2014-2019)
      • 3.2.2 Vaccine for Non-infectious Meningitis Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Vaccine for Non-infectious Meningitis Market Concentration Ratio (CR5 and HHI)
    • 3.3 Vaccine for Non-infectious Meningitis Price by Manufacturers
    • 3.4 Key Manufacturers Vaccine for Non-infectious Meningitis Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Vaccine for Non-infectious Meningitis Market
    • 3.6 Key Manufacturers Vaccine for Non-infectious Meningitis Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Polysaccharide Vaccines Sales and Revenue (2014-2019)
      • 4.1.2 Conjugate Vaccines Sales and Revenue (2014-2019)
      • 4.1.3 Combination Vaccines Sales and Revenue (2014-2019)
      • 4.1.4 Men B Vaccines Sales and Revenue (2014-2019)
    • 4.2 Global Vaccine for Non-infectious Meningitis Sales Market Share by Type
    • 4.3 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type
    • 4.4 Vaccine for Non-infectious Meningitis Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Vaccine for Non-infectious Meningitis Sales by Application

    6 United States

    • 6.1 United States Vaccine for Non-infectious Meningitis Breakdown Data by Company
    • 6.2 United States Vaccine for Non-infectious Meningitis Breakdown Data by Type
    • 6.3 United States Vaccine for Non-infectious Meningitis Breakdown Data by Application

    7 European Union

    • 7.1 European Union Vaccine for Non-infectious Meningitis Breakdown Data by Company
    • 7.2 European Union Vaccine for Non-infectious Meningitis Breakdown Data by Type
    • 7.3 European Union Vaccine for Non-infectious Meningitis Breakdown Data by Application

    8 China

    • 8.1 China Vaccine for Non-infectious Meningitis Breakdown Data by Company
    • 8.2 China Vaccine for Non-infectious Meningitis Breakdown Data by Type
    • 8.3 China Vaccine for Non-infectious Meningitis Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Vaccine for Non-infectious Meningitis Breakdown Data by Company
    • 9.2 Rest of World Vaccine for Non-infectious Meningitis Breakdown Data by Type
    • 9.3 Rest of World Vaccine for Non-infectious Meningitis Breakdown Data by Application
    • 9.4 Rest of World Vaccine for Non-infectious Meningitis Breakdown Data by Countries
      • 9.4.1 Rest of World Vaccine for Non-infectious Meningitis Sales by Countries
      • 9.4.2 Rest of World Vaccine for Non-infectious Meningitis Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Serum Institute (India)
      • 10.1.1 Serum Institute (India) Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Vaccine for Non-infectious Meningitis
      • 10.1.4 Vaccine for Non-infectious Meningitis Product Introduction
      • 10.1.5 Serum Institute (India) Recent Development
    • 10.2 Sanofi SA (France)
      • 10.2.1 Sanofi SA (France) Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Vaccine for Non-infectious Meningitis
      • 10.2.4 Vaccine for Non-infectious Meningitis Product Introduction
      • 10.2.5 Sanofi SA (France) Recent Development
    • 10.3 Pfizer (USA)
      • 10.3.1 Pfizer (USA) Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Vaccine for Non-infectious Meningitis
      • 10.3.4 Vaccine for Non-infectious Meningitis Product Introduction
      • 10.3.5 Pfizer (USA) Recent Development
    • 10.4 Nuron Biotech (USA)
      • 10.4.1 Nuron Biotech (USA) Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Vaccine for Non-infectious Meningitis
      • 10.4.4 Vaccine for Non-infectious Meningitis Product Introduction
      • 10.4.5 Nuron Biotech (USA) Recent Development
    • 10.5 JN-International Medical (USA)
      • 10.5.1 JN-International Medical (USA) Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Vaccine for Non-infectious Meningitis
      • 10.5.4 Vaccine for Non-infectious Meningitis Product Introduction
      • 10.5.5 JN-International Medical (USA) Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Vaccine for Non-infectious Meningitis Sales Channels
      • 11.2.2 Vaccine for Non-infectious Meningitis Distributors
    • 11.3 Vaccine for Non-infectious Meningitis Customers

    12 Market Forecast

    • 12.1 Global Vaccine for Non-infectious Meningitis Sales and Revenue Forecast 2019-2025
    • 12.2 Global Vaccine for Non-infectious Meningitis Sales Forecast by Type
    • 12.3 Global Vaccine for Non-infectious Meningitis Sales Forecast by Application
    • 12.4 Vaccine for Non-infectious Meningitis Forecast by Regions
      • 12.4.1 Global Vaccine for Non-infectious Meningitis Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Vaccine for Non-infectious Meningitis Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.
      In 2019, the market size of Vaccine for Non-infectious Meningitis is 1 million US$ and it will reach 2 million US$ in 2025, growing at a CAGR of 12.0% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Vaccine for Non-infectious Meningitis.

      This report studies the global market size of Vaccine for Non-infectious Meningitis, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Vaccine for Non-infectious Meningitis sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Serum Institute (India)
      Sanofi SA (France)
      Pfizer (USA)
      Nuron Biotech (USA)
      JN-International Medical (USA)
      ...

      Market Segment by Product Type
      Polysaccharide Vaccines
      Conjugate Vaccines
      Combination Vaccines
      Men B Vaccines

      Market Segment by Application
      Meningitis
      Septicemia
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Vaccine for Non-infectious Meningitis status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Vaccine for Non-infectious Meningitis manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Vaccine for Non-infectious Meningitis are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now